Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Life science research tools supplier Abcam reported a fall in annual profit after taking a £12.8m hit from costs associated with the transition of operations to its cloud-based ERP system.
For the 12 months ended 30 June 2019, reported pre-tax profit declined to £56.4m from £69.1m a year earlier and total revenue was up 11.4%.
The company detailed a new five-year plan targeting revenue of £450 to £500m in 2023 and 2024, with adjusted operating profit margin expected to reach the low-30s in percentage terms.
The company proposed a final dividend of 8.58p, unchanged on last year, taking the proposed total annual dividend to 12.13p per share, an increase of 1.1%.
Trading performance for year to date was in line with the company's expectations, with total revenue for the year expected to be in the range of £288 to £294m, equivalent to constant currency revenue growth of 9% to 11%.
The company also estimated that adjusted operating profit would in the range of 25% to 28%, and total capital expenditure in the region of £30m of 50m.
At 8:38am: (LON:ABC) Abcam PLC share price was -116p at 1124p